To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful., changes federal law or congressional policy affecting transportation operators and travelers. The main policy domain is Transportation, Trade, Healthcare.
Who Benefits and How
transportation operators and travelers may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, transportation operators and travelers may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HAB6E54FD911048FE8DF99386509918FC: 1. Short title This Act may be cited as the Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act or the STOP Fentanyl and Xylazine...
- Section HCA8F2F015C9D4078BD96143844D44A9E: 2. Clarification regarding the treatment of equipment that indicates the presence of fentanyl or xylazine in a compound Section 422 of the Controlled...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful., changes federal law or congressional policy affecting transportation operators and travelers.
Key Policy Areas
Transportation, Trade, Healthcare
Primary Purpose
This bill, To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful., changes federal law or congressional policy affecting transportation operators and travelers.
Policy Domains
Whole bill
Identified Gains
- transportation operators and travelers
Identified Costs
- federal implementing agencies
- transportation operators and travelers
Sponsors
Legislative Progress
IntroducedMs. Crockett (for herself and Mr. Gooden) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology